From: NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway
Parameter | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Age (y) | 1.030 | 0.697–1.523 | 0.882 | |||
Sex | 0.963 | 0.654–1.418 | 0.848 | |||
Clinical stage | 1.834 | 1.528–2.201 | < 0.001 | 2.200 | 1.092–2.591 | 0.002 |
T classification | 1.645 | 1.304–2.076 | < 0.001 | 1.121 | 0.861–1.459 | 0.396 |
N classification | 1.931 | 1.559–2.393 | < 0.001 | 0.977 | 0.656–1.454 | 0.908 |
Metastasis | 2.136 | 1.135–4.020 | 0.019 | 0.358 | 0.114–1.130 | 0.080 |
NCAPG | 2.048 | 1.348–3.111 | < 0.001 | 1.682 | 1.092–2.591 | 0.018 |